GT Biopharma annual free cash flow
2011
2012
2013
2014
2015
2016
2017
2018
2019
GT Biopharma Free Cash Flow (FCF) History (GTBP)
GT Biopharma reported −$3.7M in free cash flow for fiscal 2019, an increase of $7.1M from the previous fiscal year.
View full GT Biopharma company overviewGT Biopharma free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2019 | 2019-12-31 | −$3.7M | $7.1M | — | — |
| 2018 | 2018-12-31 | −$10.7M | −$5.3M | — | — |
| 2017 | 2017-12-31 | −$5.4M | −$3.5M | — | — |
| 2016 | 2016-12-31 | −$1.9M | $2.7M | — | — |
| 2015 | 2015-12-31 | −$4.7M | −$2.9M | — | −17251.85% |
| 2014 | 2014-12-31 | −$1.8M | −$1.3M | — | −2877.05% |
| 2013 | 2013-12-31 | −$442,000 | $547,000 | — | −120.11% |
| 2012 | 2012-12-31 | −$989,000 | −$26,000 | — | −289.18% |
| 2011 | 2011-12-31 | −$963,000 | — | — | −3703.85% |
GT Biopharma quarterly free cash flow
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q4 2019 | 2019-12-31 | −$485,000 | $791,000 | — | — |
| Q3 2019 | 2019-09-30 | −$1.1M | $2.3M | — | — |
| Q2 2019 | 2019-06-30 | −$1.1M | $687,000 | — | — |
| Q1 2019 | 2019-03-31 | −$961,000 | $3.3M | — | — |
| Q4 2018 | 2018-12-31 | −$1.3M | $880,000 | — | — |
| Q3 2018 | 2018-09-30 | −$3.4M | −$1.2M | — | — |
| Q2 2018 | 2018-06-30 | −$1.8M | −$1.4M | — | — |
| Q1 2018 | 2018-03-31 | −$4.2M | −$3.6M | — | — |
| Q4 2017 | 2017-12-31 | −$2.2M | — | — | — |
| Q3 2017 | 2017-09-30 | −$2.2M | — | — | — |
| Q2 2017 | 2017-06-30 | −$391,000 | — | — | — |
| Q1 2017 | 2017-03-31 | −$650,000 | — | — | — |
GT Biopharma free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from −$1.8M to −$3.7M, a net decrease of $1.9M. GT Biopharma's latest reported quarter, Q4 2019, generated −$485,000 in free cash flow, an increase of $791,000 year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review GT Biopharma filings at SEC.gov ↗